Merck & Co., Inc.

Holdings as of Sep 30, 2026 · filed Nov 13, 2026

$820348090
Portfolio value
13
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Moderna Inc $444488148 54.18% — Held
2 Personalis Inc $228651672 27.87% — Held
3 Kymera Therapeutics Inc $86320325 10.52% — Held
4 Aktis Oncology Inc $18551873 2.26% — Held
5 Eikon Therapeutics Inc $13399995 1.63% — Held
6 Entrada Therapeutics Inc $11047527 1.35% — Held
7 Alector Inc $6559581 0.80% — Held
8 Sutro Biopharma Inc $4387575 0.53% — Held
9 Evaxion As $3982333 0.49% — Held
10 Viridian Therapeutics Inc $1923394 0.23% — Held
11 Xilio Therapeutics Inc $959137 0.12% — Held
12 Tuhura Biosciences Inc $40834 0.00% — Held
13 Neuphoria Therapeutics Inc $35696 0.00% — Held

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.